Literature DB >> 15736366

Systemic effects of intravesical BCG treatment.

B Little, M R A Young, R Convery.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 15736366     DOI： 10.1007/bf03170515

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  3 in total

1.  Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.

Authors:  A Steg; C Leleu; B Debré; L Boccon-Gibod; D Sicard
Journal:  Prog Clin Biol Res       Date:  1989

2.  Pulmonary disease following intravesical BCG treatment.

Authors:  S Kesten; L Title; B Mullen; R Grossman
Journal:  Thorax       Date:  1990-09       Impact factor: 9.139

3.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.